Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.71 USD
Change Today +0.03 / 4.41%
Volume 218.4K
XXII On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 6:40 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

9530 Main Street

Clarence, NY 14031

United States

Phone: 716-270-1523

Fax: 716-877-3064

22nd Century Group, Inc. operates as a plant biotechnology company. Products RED SUN and MAGIC Cigarettes: The company’s subsidiary, Goodrich Tobacco Company, LLC (Goodrich Tobacco), introduced in a limited capacity two super-premium priced cigarette brands, RED SUN and MAGIC, into the U.S. market in 2011. Both of the RED SUN and MAGIC brands are available in regular and menthol, and all brand styles are king size and packaged in hinge-lid hard packs. SPECTRUM Government Research Cigarettes: In 2014, Goodrich Tobacco entered into a teaming agreement with RTI International (RTI) to work together to respond to a new request from National Institute on Drug Abuse (NIDA) for the potential purchase by NIDA from RTI of additional SPECTRUM research cigarettes to be produced and sold by Goodrich Tobacco to RTI. BRAND A and BRAND B: The tobacco in BRAND A contains approximately 95% less nicotine than tobacco in ‘light’ cigarette brands. Using a proprietary high nicotine tobacco blend in conjunction with specialty cigarette components, BRAND B allows the smoker to achieve a satisfactory amount of nicotine per cigarette while inhaling less ‘tar’ and carbon monoxide. X-22 Smoking Cessation Aid: X-22 is a tobacco-based botanical medical product for use as an aid to smoking cessation. The X-22 therapy protocol utilized in its sponsored Phase IIb clinical trial calls for the patient to smoke its very low nicotine (VLN) cigarettes over a six-week treatment period to facilitate the goal of the patient quitting smoking by the end of the treatment period. The company’s Investigational New Drug Application for X-22, a kit of VLN cigarettes, was cleared by the U.S. Food and Drug Administration (FDA) in 2011 and has been updated annually. Research and Development During the year ended December 31, 2014, the company incurred total research and development expenses of approximately $1,249,007. Intellectual Property The company owns or exclusively controls 128 issued patents plus an additional 52 pending patent applications. Competition In the market for FDA-approved smoking cessation aids, the company’s principal competitors include Pfizer Inc.; GlaxoSmithKline plc; Novartis International AG; and Perrigo Company plc. The company’s domestic competitors include Philip Morris USA; Reynolds American Inc.; Lorillard Inc.; Commonwealth Brands, Inc.; Liggett Group LLC; and Vector Tobacco Inc. Its international competitors include Philip Morris International, Inc.; Japan Tobacco Inc.; Imperial Tobacco Group plc; and regional and local tobacco companies. History 22nd Century Group, Inc. was founded in 1998.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XXII:US $0.71 USD +0.03

XXII Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GlaxoSmithKline PLC 1,341 GBp +9.50
Imperial Tobacco Group PLC 3,159 GBp +24.00
Perrigo Co PLC $185.42 USD -2.77
Philip Morris International Inc $80.35 USD -0.43
Reynolds American Inc $84.67 USD +0.19
View Industry Companies
 

Industry Analysis

XXII

Industry Average

Valuation XXII Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 13.6x
Price/Book 2.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact 22ND CENTURY GROUP INC, please visit www.xxiicentury.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.